INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 January 2012
Total net assets |
£114.7m |
NAV per share |
206.5p |
Share price |
175.9p |
Total value of unquoted investments |
£18.2m |
Total number of portfolio companies |
68 |
Cash |
4% NAV |
Cash committed and reserved to unquoted investments |
(7)% NAV |
Portfolio companies with < 1 year of cash |
11.99% NAV |
Top Ten Holdings
Company Name |
% NAV |
Micromet |
5.1 |
Teva |
4.6 |
Gilead Sciences |
4.1 |
Amgen |
3.8 |
Insulet |
3.8 |
Celgene Alexion Pharmaxis |
3.2 3.1 2.9 |
Aptiv Shire |
2.8 2.7 |
|
----------- |
Total |
36.1 |
Geographical Allocation |
% |
United States |
74 |
Europe |
14 |
Israel |
5 |
Australia |
3 |
Cash |
4 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
80 |
Unquoted |
16 |
Cash |
4 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
17 FEBRUARY 2012